GlassScriptPhysician profile
Rajesh Ravuri
NPI 1952386112
$795.00
in general payments reported to CMS, 2019-2025
20 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $476 · 2020: $81.01 · 2022: $171 · 2023: $67.25.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $67.25.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $67.25 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $86.55 | 2022 | |
| Glaxosmithkline, LLC. | $69.73 | 2019-2023 | Shingrix |
| Novartis Pharmaceuticals Corporation | $66.63 | 2019 | |
| Medtronic Minimed, INC. | $60.89 | 2019 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $59.18 | 2019-2022 | |
| Pfizer INC. | $56.53 | 2019 | |
| Amgen INC. | $53.48 | 2019-2020 | |
| Janssen Pharmaceuticals, INC | $49.42 | 2019-2020 | |
| Astrazeneca Pharmaceuticals LP | $41.76 | 2019-2020 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $34.64 | 2019 | |
| Ferring Pharmaceuticals INC. | $30.74 | 2019 | |
| Astellas Pharma US INC | $29.60 | 2023 | Veozah |
| Mylan Specialty L.P. | $24.49 | 2019 | |
| Allergan, INC. | $23.02 | 2019 | |
| Tandem Diabetes Care, INC. | $22.31 | 2023 | T:Slim X2 Insulin Pump With Control-Iq |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $19.49 | 2019 | |
| Sanofi-Aventis U.S. LLC | $18.65 | 2020 | |
| Dynavax Technologies Corporation | $18.13 | 2022 | |
| Otsuka America Pharmaceutical, INC. | $16.39 | 2020 | |
| Lilly USA, LLC | $13.37 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Rajesh Ravuri listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.